Filing Flows

Filing Flows › ImageneBio (IMA) › Who owns the stock

Who owns ImageneBio (IMA) stock

33 funds reported ImageneBio (IMA) shares in their latest 13F filings, worth $33.0M in all. The largest holder is BVF ($6.5M). Last quarter 12 funds added to their stakes and 17 cut them.

Largest holders of IMA (13F)Largest holders of IMA (13F)BVF$6.5MOrbimed Advisors LLC$5.4MCable Car Capital, LP$4.6MOmega Fund Management, LLC$2.7MRTW Investments, LP$2.0MVanguard Capital Management LLC$1.9MTrails Edge Capital Partners, LP$1.7MVanguard Group$1.6MBML Capital Management, LLC$1.2MMonashee Investment Management LLC$1.1M

Largest holders (13F)

FundSharesValueChangeQuarter
BVF1,110,002$6.5Munchanged2026-06-30
Orbimed Advisors LLC909,269$5.4Mincrease2026-06-30
Cable Car Capital, LP781,599$4.6Mincrease2026-06-30
Omega Fund Management, LLC455,361$2.7Munchanged2026-06-30
RTW Investments, LP334,445$2.0Munchanged2026-06-30
Vanguard Capital Management LLC320,518$1.9Mdecrease2026-06-30
Trails Edge Capital Partners, LP282,004$1.7Mnew2026-06-30
Vanguard Group238,000$1.6Mincrease2025-12-31
BML Capital Management, LLC200,730$1.2Munchanged2026-06-30
Monashee Investment Management LLC192,344$1.1Mnew2026-06-30
BlackRock135,090$797Kincrease2026-06-30
Renaissance Technologies LLC86,930$513Kincrease2026-06-30
Adage Capital Partners GP, L.L.C.66,666$393Kunchanged2026-06-30
Citadel Advisors LLC55,610$328Kdecrease2026-06-30
Geode Capital Management, LLC53,512$316Kdecrease2026-06-30

ImageneBio's latest quarter

ImageneBio, Q1 2025: revenue $800K, net loss $8.6M, operating cash flow −$10.6M. The chart follows the revenue to costs, profit and cash.

Questions

Who owns the most IMA stock?

By the latest 13F filings: BVF ($6.5M); Orbimed Advisors LLC ($5.4M); Cable Car Capital, LP ($4.6M); Omega Fund Management, LLC ($2.7M); RTW Investments, LP ($2.0M).

What is the short interest in IMA?

61,349 shares were sold short at the 2026-10-15 settlement, 86.74% of the float.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.